Education
About Us
Working with TipRanks
Follow Us
Amexdrug Corporation (AXRX)
:AXRX
| Dec 17 | Dec 16 | |
|---|---|---|
| Income Statement | ||
| Total Revenue | $ 10.43M | $ 9.30M |
| Gross Profit | $ 1.96M | $ 1.60M |
| Operating Income | $ 214.62K | $ 145.63K |
| EBITDA | $ 226.81K | $ 152.38K |
| Net Income | $ 111.36K | $ 73.76K |
| Balance Sheet | ||
| Cash & Short-Term Investments | $ 245.03K | $ 222.18K |
| Total Assets | $ 2.31M | $ 2.33M |
| Total Debt | $ 799.66K | $ 808.02K |
| Net Debt | $ 564.24K | $ 589.45K |
| Total Liabilities | $ 1.51M | $ 1.63M |
| Stockholders' Equity | $ 806.69K | $ 697.60K |
| Cash Flow | ||
| Free Cash Flow | $ 27.49K | $ -121.20K |
| Operating Cash Flow | $ 27.49K | $ -121.20K |
| Investing Cash Flow | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ -10.63K | $ 104.07K |
Amexdrug Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.